Humalog((R)) KwikPen: an insulin-injecting pen designed for ease of use.
Author(s): Schwartz SL, Ignaut DA, Bodie JN
Affiliation(s): DGD Research, 5107 Medical Drive, San Antonio, TX 78229, USA.
Publication date & source: 2010-11, Expert Rev Med Devices., 7(6):735-43.
Insulin pens offer significant benefits over vial and syringe injections for patients with diabetes who require insulin therapy. Insulin pens are more discreet, easier for patients to hold and inject, and provide better dosing accuracy than vial and syringe injections. The Humalog((R)) KwikPen (prefilled insulin lispro [Humalog] pen, Eli Lilly and Company, Indianapolis, IN, USA) is a prefilled insulin pen highly rated by patients for ease of use in injections, and has been preferred by patients to both a comparable insulin pen and to vial and syringe injections in comparator studies. Together with an engineering study demonstrating smoother injections and reduced dosing error versus a comparator pen, recent evidence demonstrates the Humalog KwikPen device is an accurate, easy-to-use, patient-preferred insulin pen.
|